(PharmaNewsWire.Com, May 21, 2021 ) The growth of this market is primarily driven by the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against...
(PharmaNewsWire.Com, May 21, 2021 ) The growth of the global albumin & creatinine tests market is driven by factors such as the growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.The report Albumin & Creatinine Tests...
(PharmaNewsWire.Com, May 20, 2021 ) The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The presence of a large geriatric and target patient population and the improving healthcare infrastructure...
(PharmaNewsWire.Com, May 20, 2021 ) The neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. The demand for neurodiagnostics products is expected to grow mainly due to factors such as the increasing prevalence of neurological disorders...
(PharmaNewsWire.Com, May 20, 2021 ) The global peripheral vascular devices market size is projected to reach USD 12.6 billion by 2025 from USD 9.2 billion in 2020, at a CAGR of 6.5% during the forecast period.Growth in this market is majorly driven by the rapid growth in the geriatric population...
(PharmaNewsWire.Com, May 20, 2021 ) The study involved four major activities in estimating the current size of the HLA typing for the transplants market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments.According to the new market research...
(PharmaNewsWire.Com, May 20, 2021 ) This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental...
(PharmaNewsWire.Com, May 20, 2021 ) The veterinary pain management market was valued at USD 1.06 Billion in 2017 and is projected to reach USD 1.66 Billion by 2023, at a CAGR of 8.0% during the forecast period.Market growth can be attributed to growth in companion animal adoption, increasing number...
(PharmaNewsWire.Com, May 20, 2021 ) The study involved four major activities in estimating the current size for the protein A resin market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions,...
(PharmaNewsWire.Com, May 20, 2021 ) Major Growth Drivers:Market growth can be attributed to the growing need to minimize medication wastage, high rate of medication nonadherence, and technological advancements such as remote dispensing systems. On the other hand, high installation and maintenance...
(PharmaNewsWire.Com, May 20, 2021 ) Market growth can be attributed to the growing need to curtail escalating healthcare costs, shift from inpatient to outpatient surgical procedures, and growing demand for IT solutions such as mhealth, telehealth, and remote patient monitoring for better management....
(PharmaNewsWire.Com, May 20, 2021 ) The global surgical drapes and gowns market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%. The increasing number of surgeries and growing incidence of hospital-acquired infections are the key factors driving the...
(PharmaNewsWire.Com, May 20, 2021 ) Growth in this market is driven majorly by the growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals.According to the new market...
(PharmaNewsWire.Com, May 20, 2021 ) Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, the increasing prevalence of cancer and other chronic and infectious diseases,...
(PharmaNewsWire.Com, May 20, 2021 ) The stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries, high demand for the outsourcing of bioprocess validation services and rising R&D spending in the life science are...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
